Astellas to pump $352 million into Irish manufacturing facility
The Japanese firm Astellas Pharma will apply for planning permission to construct a drug manufacturing facility in Tralee, Co. Kerry, Ireland worth around €330 million ($352 million).
Stay updated with breaking news from Michael Lohan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Japanese firm Astellas Pharma will apply for planning permission to construct a drug manufacturing facility in Tralee, Co. Kerry, Ireland worth around €330 million ($352 million).
Astellas Pharma, a pharmaceutical company, plans to submit a planning application for the construction of a brand-new, €330 million state-of-the-art facility...
/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced its intention to submit a planning application...
Chat GPT creator seeking to expand in Europe
Astellas Pharma has announced that it is to invest more than €330 million in a new state of the art facility in Tralee.The Tokyo based company already has a fac...